Cannabis stocks may be highly controversial, but they could soon see higher highs.
Look at Tilray (TLRY), for example.


After dropping from about $3.40 to $2.40, the stock appears to have caught strong support. Better, there are key catalysts nearing. For one, this coming week, the Senate Banking, Housing, and Urban Affairs Committee is expected to hold a session for the SAFE Banking Act, which may have enough votes to pass. Two, the U.S. Department of Health and Human Services wants to downgrade cannabis to a Category 3 drug.
And three, House Democrats just filed a Marijuana Legalization and Expungements Bill, which, if it goes through could be another sizable catalyst.
Sincerely,
Ian Cooper
Recent Comments